Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.370
+0.120 (5.33%)
May 20, 2026, 3:41 PM EDT - Market open

Daré Bioscience Revenue

Daré Bioscience had revenue of $152.46K in the quarter ending March 31, 2026, with 499.58% growth. This brings the company's revenue in the last twelve months to $1.16M, up 4,366.48% year-over-year. In the year 2025, Daré Bioscience had annual revenue of $1.03M with 10,429.33% growth.

Revenue (ttm)
$1.16M
Revenue Growth
+4,366.48%
P/S Ratio
29.12
Revenue / Employee
$48,218
Employees
24
Market Cap
35.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03M1.02M10,429.33%
Dec 31, 20249.78K-2.80M-99.65%
Dec 31, 20232.81M-7.19M-71.92%
Dec 31, 202210.00M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 201480.00K74.00K1,233.33%
Dec 31, 20136.00K-619.00K-99.04%
Dec 31, 2012625.00K619.00K10,316.67%
Dec 31, 20116.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veru Inc.16.89M
Apollomics8.84M
Evaxion7.53M
Aligos Therapeutics4.71M
Actinium Pharmaceuticals90.00K
Revenue Rankings